TNBC does not express a progesterone receptor (PR), a tyrosine kinase receptor-2 (ERB2), and an estrogen receptor (ER), so it is insensitive to standard targeted therapeutic agents for breast cancer and can only be treated with chemotherapy (Biswas and Rao, 2017). This evidence concerns the gene PGR and breast cancer.